Immunohistochemistry for CCR4 C‐terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T‐cell leukemia/lymphoma-Reference-Cited by-同舟云学术

Immunohistochemistry for CCR4 C‐terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T‐cell leukemia/lymphoma

Published:2020-10-06 Issue:1 Volume:7 Page:52-60
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Pathol Clin Res

Author:

Fujii Keiichiro¹,Sakamoto Yuma¹,Masaki Ayako¹,Murase Takayuki¹,Tashiro Yukie²,Yonekura Kentaro³,Utsunomiya Atae⁴,Ito Asahi⁵,Kusumoto Shigeru⁵,Iida Shinsuke⁵,Ueda Ryuzo⁶,Ishida Takashi⁷,Inagaki Hiroshi¹^ORCID

Affiliation:

1. Department of Pathology and Molecular Diagnostics, Graduate School of Medical Sciences Nagoya City University Nagoya Japan

2. Department of Pathology Imamura General Hospital Kagoshima Japan

3. Department of Dermatology Imamura General Hospital Kagoshima Japan

4. Department of Hematology Imamura General Hospital Kagoshima Japan

5. Department of Hematology and Oncology, Graduate School of Medical Sciences Nagoya City University Nagoya Japan

6. Department of Tumor Immunology Aichi Medical University School of Medicine Nagakute Japan

7. Department of Immunology Nagoya University Graduate School of Medicine Nagoya Japan

Funder

Aichi Cancer Research Foundation

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cjp2.180

Reference29 articles.

1. Adult T-cell leukemia: clinical and hematologic features of 16 cases

2. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma

3. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation

4. Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma

5. Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments;Critical Reviews in Oncology/Hematology;2024-09

2. Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review;International Journal of Molecular Sciences;2024-02-12

3. Updates in Immunohistochemistry for Hematopoietic and Lymphoid Neoplasms;Archives of Pathology & Laboratory Medicine;2023-06-01

4. Mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma: a case study;International Journal of Hematology;2022-09-09

5. Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma;Blood;2022-06-30